首页> 外文期刊>Sleep & breathing =: Schlaf & Atmung >Autotitration positive airway pressure therapy in patients with obstructive sleep apnea who are intolerant of fixed continuous positive airway pressure.
【24h】

Autotitration positive airway pressure therapy in patients with obstructive sleep apnea who are intolerant of fixed continuous positive airway pressure.

机译:对于不能持续固定的持续气道正压耐受性的阻塞性睡眠呼吸暂停患者,采用自动滴定气道正压治疗。

获取原文
获取原文并翻译 | 示例
           

摘要

Compliance with continuous positive airway pressure (CPAP) therapy is one of the most difficult management problems for patients with obstructive sleep apnea (OSA). We postulated that autotitration positive airway pressure (APAP) may be effective in some patients who have an intolerance of fixed CPAP. The study was done to estimate how often patients who cannot tolerate fixed CPAP can tolerate APAP. We identified 25 patients seen in the Sleep Disorders Center who had been treated with fixed CPAP for OSA and were intolerant of CPAP therapy despite multiple efforts to improve tolerance. We substituted APAP therapy and measured subjective and objective compliance with treatment 1 month later. The primary end point was the number of patients who successfully tolerated the use of APAP at the end of 30 days, measured objectively by the device's compliance monitor. A positive outcome was defined as an average use of APAP that was greater than 3 h per night on more than 70% of possible nights. Of the 25 patients (mean age, 68 years; mean apnea-hypopnea index, 35), 11 were able to tolerate APAP therapy. The mean number of hours of use in these responders was 6.2; the mean percentage of nights of use among responders was 89%. Determinants of successful APAP use were an apnea-hypopnea index (AHI) less than 18, male sex, OSA related to rapid eye movement, and a high body mass index. APAP therapy may be an effective option in patients who do not tolerate fixed-CPAP therapy.
机译:对于阻塞性睡眠呼吸暂停(OSA)患者,持续持续气道正压通气(CPAP)治疗的依从性是最困难的管理问题之一。我们假设自动滴定气道正压通气(APAP)在某些不耐受固定CPAP的患者中可能有效。这项研究的目的是估计不能耐受固定CPAP的患者可以耐受APAP的频率。我们确定了在睡眠障碍中心看到的25例患者,他们接受了固定CPAP进行OSA的治疗,尽管为提高耐受性付出了许多努力,但他们都不耐受CPAP疗法。我们替代了APAP治疗,并在1个月后测量了治疗的主观和客观依从性。主要终点是通过设备的依从性监控器客观衡量的,在30天结束时成功耐受APAP使用的患者数量。阳性结果定义为在超过70%的夜晚中平均每晚使用APAP超过3小时。 25例患者(平均年龄68岁;平均呼吸暂停低通气指数为35)中,有11例能够耐受APAP治疗。这些响应者的平均使用小时数为6.2;回应者中平均使用晚数百分比为89%。成功使用APAP的决定因素是呼吸暂停-呼吸不足指数(AHI)小于18,男性,与快速眼动有关的OSA和高体重指数。对于不耐受固定CPAP治疗的患者,APAP治疗可能是一种有效的选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号